Age-associated proinflammatory secretory phenotype in vascular smooth muscle cells from the non-human primate macaca mulatta: Reversal by resveratrol treatment

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 67 A, Issue 8, 2012, Pages 811-820

  Csiszar, Anna ^a   Sosnowska, Danuta ^a   Wang, Mingyi ^b   Lakatta, Edward G ^b   Sonntag, William E ^a   Ungvari, Zoltan ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

3,5,4 trihydroxy trans stilbene; Cytokine; Inflammation; Oxidative stress; Vascular aging

Indexed keywords

ANIMALIA; MACACA MULATTA; PRIMATES;

5 (6' TRIPHENYLPHOSPHONIUMHEXYL) 5,6 DIHYDRO 6 PHENYL 3,8 PHENANTHRIDINEDIAMMINE; 5-(6'-TRIPHENYLPHOSPHONIUMHEXYL)-5,6-DIHYDRO-6-PHENYL-3,8-PHENANTHRIDINEDIAMMINE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN; PHENANTHRIDINE DERIVATIVE; RESVERATROL; STILBENE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANIMAL MODEL; ARTICLE; CELL AGING; CELL CULTURE; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; RHESUS MONKEY; SECRETION (PROCESS); SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL AGING; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOKINES; INTERLEUKINS; MACACA MULATTA; MODELS, ANIMAL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; OXIDATIVE STRESS; OXYGEN; PHENANTHRIDINES; STILBENES; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84861865625     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glr228     Document Type: Article

References (84)

1. Ungvari Z, Kaley G, de Cabo R, Sonntag WE, Csiszar A. Mechanisms of vascular aging: new perspectives. J Gerontol A Biol Sci Med Sci. 2010; 65: 1028 - 1041.
2. Csiszar A, Ungvari Z, Koller A, Edwards JG, Kaley G. Aging-induced proinfl ammatory shift in cytokine expression profi le in rat coronary arteries. FASEB J. 2003; 17: 1183 - 1185.
3. Ungvari ZI, Orosz Z, Labinskyy N, et al. Increased mitochondrial H2O2 production promotes endothelial NF-kB activation in aged rat arteries. Am J Physiol Heart Circ Physiol. 2007; 293: H37 - H47.
4. Smoliga JM, Vang O, Baur JA. Challenges of translating basic research into therapeutics: resveratrol as an example. J Gerontol A Biol Sci Med Sci. 2011; doi:10.1093/gerona/glr062.
5. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006; 444: 337 - 342.
6. Pearson KJ, Baur JA, Lewis KN, et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab. 2008; 8: 157 - 168.
7. Jackson JR, Ryan MJ, Alway SE. Long-term supplementation with resveratrol alleviates oxidative stress but does not attenuate sarcopenia in aged mice. J Gerontol A Biol Sci Med Sci. 2011; 66: 751 - 764.
8. Ryan MJ, Jackson JR, Hao Y, et al. Suppression of oxidative stress by resveratrol after isometric contractions in gastrocnemius muscles of aged mice. J Gerontol A Biol Sci Med Sci. 2010; 65: 815 - 831.
9. Barger JL, Kayo T, Vann JM, et al. A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS One. 2008; 3: e2264.
10. Dasgupta B, Milbrandt J. Resveratrol stimulates AMP kinase activity in neurons. Proc Natl Acad Sci U S A. 2007; 104: 7217 - 7222.
11. Csiszar A, Labinskyy N, Podlutsky A, et al. Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinfl ammatory phenotypic alterations. Am J Physiol Heart Circ Physiol. 2008; 294: H2721 - H2735.
12. Csiszar A, Smith K, Labinskyy N, Orosz Z, Rivera A, Ungvari Z. Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: role of NF-kappaB inhibition. Am J Physiol Heart Circ Physiol. 2006; 291: H1694 - H1699.
13. Ungvari Z, Bailey-Downs L, Gautam T, et al. Age-associated vascular oxidative stress, Nrf2 dysfunction and NF-{kappa}B activation in the non-human primate Macaca mulatta. J Gerontol A Biol Sci Med Sci. 2011; 66: 866 - 875.
14. Asai K, Kudej RK, Shen YT, et al. Peripheral vascular endothelial dysfunction and apoptosis in old monkeys. Arterioscler Thromb Vasc Biol. 2000; 20: 1493 - 1499.
15. Shi Q, Aida K, Vandeberg JL, Wang XL. Passage-dependent changes in baboon endothelial cells - relevance to in vitro aging. DNA Cell Biol. 2004; 23: 502 - 509.
16. de Magalhaes JP, Costa J, Church GM. An analysis of the relationship between metabolism, developmental schedules, and longevity using phylogenetic independent contrasts. J Gerontol A Biol Sci Med Sci. 2007; 62: 149 - 160.
17. Csiszar A, Labinskyy N, Perez V, et al. Endothelial function and vascular oxidative stress in long-lived GH/IGF-defi cient Ames dwarf mice. Am J Physiol Heart Circ Physiol. 2008; 295: H1882 - H1894.
18. Ungvari Z, Labinskyy N, Mukhopadhyay P, et al. Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Heart Circ Physiol. 2009; 297: H1876 - H1881.
19. Ungvari Z, Bagi Z, Feher A, et al. Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2. Am J Physiol Heart Circ Physiol. 2010; 299: H18 - H24.
20. Ungvari Z, Bailey-Downs L, Gautam T, et al. Adaptive induction of NF-E2 - related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia. Am J Physiol Heart Circ Physiol. 2011; 300: 1133 - 1140.
21. Csiszar A, Ahmad M, Smith KE, et al. Bone morphogenetic protein-2 induces proinfl ammatory endothelial phenotype. Am J Pathol. 2006; 168: 629 - 638.
22. Csiszar A, Ungvari Z, Koller A, Edwards JG, Kaley G. Proinfl ammatory phenotype of coronary arteries promotes endothelial apoptosis in aging. Physiol Genomics. 2004; 17: 21 - 30.
23. Csiszar A, Smith KE, Koller A, Kaley G, Edwards JG, Ungvari Z. Regulation of bone morphogenetic protein-2 expression in endothelial cells: role of nuclear factor-kappaB activation by tumor necrosis factoralpha, H2O2, and high intravascular pressure. Circulation. 2005; 111: 2364 - 2372.
24. Ungvari Z, Gautam T, Koncz P, et al. Vasoprotective effects of life span-extending peripubertal GH replacement in Lewis dwarf rats. J Gerontol A Biol Sci Med Sci. 2010; 65: 1145 - 1156.
25. Ungvari Z, Philipp EE. Comparative gerontology - from mussels to man. J Gerontol A Biol Sci Med Sci. 2011; 66: 295 - 297.
26. Ungvari Z, Ridgway I, Philipp EE, et al. Extreme longevity is associated with increased resistance to oxidative stress in Arctica islandica, the longest-living non-colonial animal. J Gerontol A Biol Sci Med Sci. 2011; 66 (7): 741 - 750.
27. Ungvari Z, Sosnowska D, Podlutsky A, Koncz P, Sonntag WE, Csiszar A. Free radical production, antioxidant capacity, and oxidative stress response signatures in fi broblasts from Lewis dwarf rats: effects of life span-extending peripubertal GH treatment. J Gerontol A Biol Sci Med Sci. 2011; 66 (5): 501 - 510.
28. Behrens MI, Silva M, Schmied A, et al. Age-dependent increases in apoptosis/necrosis ratios in human lymphocytes exposed to oxidative stress. J Gerontol A Biol Sci Med Sci. 2011; 66: 732 - 740.
29. Chandrashekara KT, Shakarad MN. Aloe vera or resveratrol supplementation in larval diet delays adult aging in the fruit fl y, Drosophila melanogaster. J Gerontol A Biol Sci Med Sci. 2011; 66 (12): 965 - 971.
30. Chung E, Diffee GM. Effect of aging on power output properties in rat skinned cardiac myocytes. J Gerontol A Biol Sci Med Sci. 2011; 66 (12): 1267 - 1273.
31. Dekker P, de Lange MJ, Dirks RW, et al. Relation between maximum replicative capacity and oxidative stress-induced responses in human skin fi broblasts in vitro. J Gerontol A Biol Sci Med Sci. 2011; 66: 45 - 50.
32. Endt H, Sprung CN, Keller U, Gaipl U, Fietkau R, Distel LV. Detailed analysis of DNA repair and senescence marker kinetics over the life span of a human fi broblast cell line. J Gerontol A Biol Sci Med Sci. 2011; 66: 367 - 375.
33. Gunin AG, Kornilova NK, Vasilieva OV, Petrov VV. Age-related changes in proliferation, the numbers of mast cells, eosinophils, and cd45-positive cells in human dermis. J Gerontol A Biol Sci Med Sci. 2011; 66: 385 - 392.
34. McFarlane D, Wolf RF, McDaniel KA, White GL. Age-associated alteration in innate immune response in captive baboons. J Gerontol A Biol Sci Med Sci. 2011; 66 (12): 1309 - 1317.
35. Sloane LB, Stout JT, Vandenbergh DJ, Vogler GP, Gerhard GS, McClearn GE. Quantitative trait loci analysis of tail tendon break time in mice of C57BL/6J and DBA/2J lineage. J Gerontol A Biol Sci Med Sci. 2011; 66: 170 - 178.
36. Smith DL Jr, Mattison JA, Desmond RA, et al. Telomere dynamics in rhesus monkeys: no apparent effect of caloric restriction. J Gerontol A Biol Sci Med Sci. 2011; 66 (11): 1163 - 1168.
37. Zhu M, Hu J, Perez E, et al. Effects of long-term cranberry supplementation on endocrine pancreas in aging rats. J Gerontol A Biol Sci Med Sci. 2011; 66 (11): 1139 - 1151.
38. Csiszar A, Labinskyy N, Olson S, et al. Resveratrol prevents monocrotaline- induced pulmonary hypertension in rats. Hypertension. 2009; 54: 668 - 675.
39. Labbe A, Garand C, Cogger VC, et al. Resveratrol improves insulin resistance hyperglycemia and hepatosteatosis but not hypertriglyceridemia, infl ammation, and life span in a mouse model for Werner syndrome. J Gerontol A Biol Sci Med Sci. 2011; 66: 264 - 278.
40. Miller RA, Harrison DE, Astle CM, et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci. 2011; 66: 191 - 201.
41. Coppe JP, Patil CK, Rodier F, et al. A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen. PLoS One. 2010; 5: e9188.
42. Csiszar A, Labinskyy N, Pinto JT, et al. Resveratrol induces mitochondrial biogenesis in endothelial cells. Am J Physiol Heart Circ Physiol. 2009; 297 (1): H13 - H20.
43. Ungvari Z, Sonntag WE, de Cabo R, Baur JA, Csiszar A. Mitochondrial protection by resveratrol. Exerc Sport Sci Rev. 2011; 39 (3): 128 - 132.
44. Csiszar A, Wang M, Lakatta EG, Ungvari ZI. Infl ammation and endothelial dysfunction during aging: role of NF-kappaB. J Appl Physiol. 2008; 105: 1333 - 1341.
45. Hsieh TC, Lu X, Wang Z, Wu JM. Induction of quinone reductase NQO1 by resveratrol in human K562 cells involves the antioxidant response element ARE and is accompanied by nuclear translocation of transcription factor Nrf2. Med Chem. 2006; 2: 275 - 285.
46. Kode A, Rajendrasozhan S, Caito S, Yang SR, Megson IL, Rahman I. Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2008; 294: L478 - L488.
47. Rubiolo JA, Mithieux G, Vega FV. Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur J Pharmacol. 2008; 591: 66 - 72.
48. Csiszar A, Labinskyy N, Jimenez R, et al. Anti-oxidative and antiinfl ammatory vasoprotective effects of caloric restriction in aging: role of circulating factors and SIRT1. Mech Ageing Dev. 2009; 130: 518 - 527.
49. Csiszar A, Labinskyy N, Smith K, Rivera A, Orosz Z, Ungvari Z. Vasculoprotective effects of anti-tumor necrosis factor-alfa treatment in aging. Am J Pathol. 2007; 170: 388 - 698.
50. Csiszar A, Ungvari Z, Edwards JG, et al. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res. 2002; 90: 1159 - 1166.
51. Wang M, Monticone RE, Lakatta EG. Arterial aging: a journey into subclinical arterial disease. Curr Opin Nephrol Hypertens. 2010; 19: 201 - 207.
52. Jiang L, Wang M, Zhang J, et al. Increased aortic calpain-1 activity mediates age-associated angiotensin II signaling of vascular smooth muscle cells. PLoS One. 2008; 3: e2231.
53. Ungvari Z, Parrado-Fernandez C, Csiszar A, de Cabo R. Mechanisms underlying caloric restriction and lifespan regulation: implications for vascular aging. Circ Res. 2008; 102: 519 - 528.
54. Coppe JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010; 5: 99 - 118.
55. Clark HF, Gurney AL, Abaya E, et al. The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res. 2003; 13: 2265 - 2270.
56. Helenius M, Hanninen M, Lehtinen SK, Salminen A. Aging-induced up-regulation of nuclear binding activities of oxidative stress responsive NF-kB transcription factor in mouse cardiac muscle. J Mol Cell Cardiol. 1996; 28: 487 - 498.
57. Donato AJ, Black AD, Jablonski KL, Gano LB, Seals DR. Aging is associated with greater nuclear NF kappa B, reduced I kappa B alpha, and increased expression of proinfl ammatory cytokines in vascular endothelial cells of healthy humans. Aging Cell. 2008; 7: 805 - 812.
58. Gareus R, Kotsaki E, Xanthoulea S, et al. Endothelial cell-specifi c NF-kappaB inhibition protects mice from atherosclerosis. Cell Metab. 2008; 8: 372 - 383.
59. Coppe JP, Patil CK, Rodier F, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008; 6: 2853 - 2868.
60. Rodier F, Coppe JP, Patil CK, et al. Persistent DNA damage signalling triggers senescence-associated infl ammatory cytokine secretion. Nat Cell Biol. 2009; 11: 973 - 979.
61. Salminen A, Ojala J, Kaarniranta K, Haapasalo A, Hiltunen M, Soininen H. Astrocytes in the aging brain express characteristics of senescence-associated secretory phenotype. Eur J Neurosci. 2011; 34: 3 - 11.
62. Freund A, Patil CK, Campisi J. p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J. 2011; 30: 1536 - 1548.
63. Lee MY, Wang Y, Vanhoutte PM. Senescence of cultured porcine coronary arterial endothelial cells is associated with accelerated oxidative stress and activation of NFkB. J Vasc Res. 2010; 47: 287 - 298.
64. Ksiazek K, Jorres A, Witowski J. Senescence induces a proangiogenic switch in human peritoneal mesothelial cells. Rejuvenation Res. 2008; 11: 681 - 683.
65. Coppe JP, Kauser K, Campisi J, Beausejour CM. Secretion of vascular endothelial growth factor by primary human fi broblasts at senescence. J Biol Chem. 2006; 281: 29568 - 29574.
66. Abraham J, Johnson RW. Consuming a diet supplemented with resveratrol reduced infection-related neuroinfl ammation and defi cits in working memory in aged mice. Rejuvenation Res. 2009; 12: 445 - 453.
67. Zhang H, Zhang J, Ungvari Z, Zhang C. Resveratrol improves endothelial function: role of TNF{alpha} and vascular oxidative stress. Arterioscler Thromb Vasc Biol. 2009; 29: 1164 - 1171.
68. Rius C, Abu-Taha M, Hermenegildo C, et al. Trans- but not cisresveratrol impairs angiotensin-II-mediated vascular infl ammation through inhibition of NF-kappaB activation and peroxisome proliferator- activated receptor-gamma upregulation. J Immunol. 2010; 185: 3718 - 3727.
69. Venkatachalam K, Mummidi S, Cortez DM, Prabhu SD, Valente AJ, Chandrasekar B. Resveratrol inhibits high glucose-induced PI3K/Akt/ ERK-dependent interleukin-17 expression in primary mouse cardiac fi broblasts. Am J Physiol Heart Circ Physiol. 2008; 294: H2078 - H2087.
70. Zhu J, Yong W, Wu X, et al. Anti-infl ammatory effect of resveratrol on TNF-alpha-induced MCP-1 expression in adipocytes. Biochem Biophys Res Commun. 2008; 369: 471 - 477.
71. Cicha I, Regler M, Urschel K, Goppelt-Struebe M, Daniel WG, Garlichs CD. Resveratrol inhibits monocytic cell chemotaxis to MCP-1 and prevents spontaneous endothelial cell migration through Rho kinase-dependent mechanism. J Atheroscler Thromb. 2011; doi:10.5551/jat.8136.
72. Knobloch J, Hag H, Jungck D, Urban K, Koch A. Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxinexposed alveolar macrophages in chronic obstructive pulmonary disease. Basic Clin Pharmacol Toxicol. 2011; 109: 138 - 143.
73. Dugas B, Charbonnier S, Baarine M, et al. Effects of oxysterols on cell viability, infl ammatory cytokines, VEGF, and reactive oxygen species production on human retinal cells: cytoprotective effects and prevention of VEGF secretion by resveratrol. Eur J Nutr. 2010; 49: 435 - 446.
74. Wong YT, Gruber J, Jenner AM, Tay FE, Ruan R. Chronic resveratrol intake reverses pro-infl ammatory cytokine profi le and oxidative DNA damage in ageing hybrid mice. Age (Dordr). 2011; 33 (3): 229 - 246.
75. Ghanim H, Sia CL, Abuaysheh S, et al. An antiinfl ammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol. J Clin Endocrinol Metab. 2010; 95: E1 - E8.
76. Ghanim H, Sia CL, Korzeniewski K, et al. A resveratrol and polyphenol preparation suppresses oxidative and infl ammatory stress response to a high-fat, high-carbohydrate meal. J Clin Endocrinol Metab. 2011; 96: 1409 - 1414.
77. Yeung F, Hoberg JE, Ramsey CS, et al. Modulation of NF-kappaBdependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004; 23: 2369 - 2380.
78. Ungvari Z, Bailey-Downs L, Sosnowska D, et al. Vascular oxidative stress in aging: a homeostatic failure due to dysregulation of NRF2- mediated antioxidant response. Am J Physiol Heart Circ Physiol. 2011; 301: H363 - H372.
79. Bailey-Downs LC, Mitschelen M, Sosnowska D, et al. Liver-specifi c knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the Nrf2-dependent antioxidant response: a novel model of vascular aging. J Gerontol A Biol Sci Med Sci. 2011; doi:10.1093/ gerona/glr164.
80. Kim JW, Lim SC, Lee MY, et al. Inhibition of neointimal formation by trans-resveratrol: role of phosphatidyl inositol 3-kinase-dependent Nrf2 activation in heme oxygenase-1 induction. Mol Nutr Food Res. 2010; 54: 1497 - 1505.
81. Giovannelli L, Pitozzi V, Jacomelli M, et al. Protective effects of resveratrol against senescence-associated changes in cultured human fi broblasts. J Gerontol A Biol Sci Med Sci. 2011; 66: 9 - 18.
82. Mukhopadhyay P, Mukherjee S, Ahsan K, Bagchi A, Pacher P, Das DK. Restoration of altered microRNA expression in the ischemic heart with resveratrol. PLoS One. 2010; 5: e15705.
83. Mukhopadhyay P, Pacher P, Das DK. MicroRNA signatures of resveratrol in the ischemic heart. Ann N Y Acad Sci. 2011; 1215: 109 - 116.
84. Oomen CA, Farkas E, Roman V, van der Beek EM, Luiten PG, Meerlo P. Resveratrol preserves cerebrovascular density and cognitive function in aging mice. Front Aging Neurosci. 2009; 1: 4.